Nanjing Medlander Return On Equity vs. Return On Asset
| 688273 Stock | 25.66 0.54 2.15% |
For Nanjing Medlander profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nanjing Medlander to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nanjing Medlander Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nanjing Medlander's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nanjing Medlander Medical over time as well as its relative position and ranking within its peers.
Nanjing |
Nanjing Medlander Medical Return On Asset vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nanjing Medlander's current stock value. Our valuation model uses many indicators to compare Nanjing Medlander value to that of its competitors to determine the firm's financial worth. Nanjing Medlander Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nanjing Medlander Medical is roughly 2.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanjing Medlander by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanjing Medlander's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanjing Return On Asset vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Nanjing Medlander |
| = | 0.0776 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Nanjing Medlander |
| = | 0.0386 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Nanjing Return On Asset Comparison
Nanjing Medlander is currently under evaluation in return on asset category among its peers.
Nanjing Medlander Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nanjing Medlander, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nanjing Medlander will eventually generate negative long term returns. The profitability progress is the general direction of Nanjing Medlander's change in net profit over the period of time. It can combine multiple indicators of Nanjing Medlander, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 14.4 M | 15.1 M | |
| Interest Income | 14.9 M | 15.6 M | |
| Operating Income | 74.4 M | 93.4 M | |
| Net Income From Continuing Ops | 92.5 M | 92.6 M | |
| Income Before Tax | 101.5 M | 103 M | |
| Net Income | 89.8 M | 88.6 M |
Nanjing Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nanjing Medlander. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nanjing Medlander position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nanjing Medlander's important profitability drivers and their relationship over time.
Use Nanjing Medlander in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nanjing Medlander position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanjing Medlander will appreciate offsetting losses from the drop in the long position's value.Nanjing Medlander Pair Trading
Nanjing Medlander Medical Pair Trading Analysis
The ability to find closely correlated positions to Nanjing Medlander could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nanjing Medlander when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nanjing Medlander - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nanjing Medlander Medical to buy it.
The correlation of Nanjing Medlander is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nanjing Medlander moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nanjing Medlander Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nanjing Medlander can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nanjing Medlander position
In addition to having Nanjing Medlander in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Nanjing Stock
To fully project Nanjing Medlander's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nanjing Medlander Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nanjing Medlander's income statement, its balance sheet, and the statement of cash flows.